01.29.25 -- Suffering High Protein Sieving Losses? It Might Be The Buffer

Despite our lack of understanding of the mechanistic forces behind sequence design for increased recombinant protein expression yield, a better, more tailored codon optimization paradigm is achievable.

Pouring millions into the infrastructure and quality systems necessary to move away from manual filling is unrealistic and detracts from your strengths in drug development.

Aseptic processing ensures drug sterility, with filter integrity testing being critical. PUPSIT, a regulatory requirement in the EU, ensures filters remain undamaged and effective during manufacturing.

Discover how CASPON® Technology can revolutionize your recombinant protein manufacturing processes and enhance efficiency.

This protein capture device demonstration showcases a cycling protocol that uses fast loading and non-loading residence times as well as a rapid CIP out to 100 cycles.

Formulation development is a vital part of the drug development process. Explore key factors to consider in pre-formulation.

Explore two studies that indicate for a properly-assembled vial containment system, good CCI performance can be achieved with stoppers of a given elastomer, independent of configuration or vial style.

High concentration formulations often present challenges with regard to viscosity as well as potential changes in the behavior upon stability. Discover solutions to mitigate high viscosity.